
Current Formulations Private Limited
About Current Formulations Private Limited
Data last updated:
Current Formulations Private Limited is a private limited company based in Thattachavadi, Puducherry, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 February 1982 and has been in existence for over 44 years.
The company is registered with the Registrar of Companies (ROC), Pondicherry, under CIN U24239PY1982PTC000190.
The company has an authorised share capital of ₹12 Lakh and a paid-up capital of ₹8 Lakh. It is led by directors Agillavadivu Visweswaran and Visweswaran Malaikkolundumudaliar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 3 Industrial Estate Thattachavadi Pondicherry, Puducherry, India – 605009.
As per the financials filed for FY 2024, the company reported a revenue of ₹6.03 Lakh, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹8,542 (net margin 1.4%) and EBITDA of ₹39,371 (EBITDA margin 6.5%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 20% over five years.
As per MCA filings, the company has satisfied charges of ₹12.1 Cr on record. Court records list 1 case involving the company, including 1 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Current Formulations Private Limited's registered office is in Thattachavadi, Puducherry. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressB – 3 Industrial Estate Thattachavadi Pondicherry, Puducherry, India – 605009
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Current Formulations Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Current Formulations Private Limited
FY 2025 filings availableCurrent Formulations Private Limited reported revenue of ₹6.03 Lakh (down 2% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 2% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 20%. EBITDA fell 82% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹39,371 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8,542 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.5% | ||||
| Net Profit Margin | 1.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Current Formulations Private Limited, buy the company report.
Board of directors of Current Formulations Private Limited
Current Formulations has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Agillavadivu Visweswaran | Director | 20 Aug 2010 | 16 Years 3 Months | Current |
| Visweswaran Malaikkolundumudaliar | Director | 20 Aug 2010 | 16 Years 3 Months | Current |
Peer comparison
Current Formulations Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ordnc 2025 000035 U74900br2014ptc022894 Private Limited | ₹6.13 Lakh (FY 2020) | Patna, Bihar, India | ||||
| Hippocampus Health Care Private Limited | ₹6.11 Lakh (FY 2018) | 272.0% | Bangalore, Karnataka, India | |||
| Medilexicon Pharmaceuticals Private Limited | ₹6.09 Lakh (FY 2024) | 23.0% | Jaipur, Rajasthan, India | |||
| Nobel Enkem Private Limited | ₹6.08 Lakh (FY 2024) | 3.0% | Patna, Bihar, India | |||
| 1St Rate Pharma Private Limited | ₹6.05 Lakh (FY 2025) | Thane, Maharashtra, India | ||||
| Current Formulations Private Limitedthis company | ₹6.03 Lakh (FY 2024) | ₹8,542 | 1.4% | -2.0% | Thattachavadi, Puducherry, India | |
| Turquoise House of Design and Trading Private Limited | ₹6.02 Lakh (FY 2024) | -2.0% | Haryana, India | |||
| Medineutrina Private Limited | ₹6.01 Lakh (FY 2025) | 300.0% | Nagpur, Maharashtra, India | |||
| Marpu Builders Limited | ₹6 Lakh (FY 2024) | Secunderabad, Telangana, India | ||||
| Medifirst Pharma Private Limited | ₹5.99 Lakh (FY 2021) | Nashik, Maharashtra, India | ||||
| Mahi Biotech Limited | ₹5.95 Lakh (FY 2025) | -67.0% | Budaun, Uttar Pradesh, India |
To see the full peer comparison of Current Formulations Private Limited, buy the company report.
Auditor
Current Formulations Private Limited is audited by GANESAN AND COMPANY for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GANESAN AND COMPANY | FY 2022 | 000859S |
Shareholding
The shareholding of Current Formulations Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Current Formulations Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Apr 2005 | 90005903 | Karnataka Bank Limited | ₹12.1 Cr | Satisfied |
To see the full charge records of Current Formulations Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Current Formulations Private Limited has 1 court case on record: 1 filed by Current Formulations. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Puducherry | Execution petition | Filed by the company against Onsky Technology Pvt Ltd, by Directors and 1 other | Disposed |
To see the full case history of Current Formulations Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Current Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Current Formulations Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Current Formulations Private Limited has 4 board changes on record since 2010: 2 appointments and 2 cessations. The latest: Mukesh Parsuram Patel ceased to be Director on 27 Aug 2010.
Frequently asked questions
Current Formulations is an active private limited company based in Thattachavadi, Puducherry, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 February 1982 (44+ years old) and is registered under CIN U24239PY1982PTC000190.
Current Formulations has 2 current directors:
- Agillavadivu Visweswaran - Director
- Visweswaran Malaikkolundumudaliar - Director
The latest financial statements of Current Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Current Formulations is U24239PY1982PTC000190. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Current Formulations has 1 court case on record: 1 filed by the company.
Current Formulations was incorporated on 19 February 1982, making it 44+ years old. It is registered with the Registrar of Companies, Pondicherry.
The peers of Current Formulations by revenue are Ordnc 2025 000035 U74900br2014ptc022894 Private Limited, Hippocampus Health Care Private Limited, Medilexicon Pharmaceuticals Private Limited, Nobel Enkem Private Limited, 1St Rate Pharma Private Limited and 5 more, all in the Pharma industry (Formulations).
Mukesh Parsuram Patel ceased to be Director on 27 Aug 2010. Pankaj Krishnakant Patel ceased to be Director on 27 Aug 2010. Agillavadivu Visweswaran was appointed as Director on 20 Aug 2010. Current Formulations has 4 board changes on record in total.
The registered office of Current Formulations is at B – 3 Industrial Estate Thattachavadi Pondicherry, Puducherry, India – 605009.
Current Formulations operates in the pharma industry, in the drug formulation and development segment.
Current Formulations has no open charges and satisfied charges of ₹12.1 Cr as per latest MCA filings.

